Daring discourse: economics of neuromodulation for the treatment of persistent spinal pain syndrome and complex regional pain syndrome

Abstract

The treatment options for patients with chronic pain conditions are impacted by recent research, patient needs, and insurance coverage. Although various factors affect the cost of healthcare, the economic burden on the patient and the healthcare system must be considered when choosing the appropriate treatments for each patient. This Daring Discourse aims to review and further clarify existing economic evaluations and thus examine cost-effectiveness with regards to neuromodulation for the treatment of persistent spinal pain syndrome and complex regional pain syndrome. Specific consideration is given to spinal cord stimulation, as it is a widely studied and implemented neuromodulation modality for the treatment of these debilitating conditions.

Editors’ comments for special edition on neuromodulation for pain syndromes

“…In terms of ‘value’ (outcomes/costs) of SCS, Provenzano and Heller present a debate on the cost-effectiveness of SCS in treating common pain syndromes including persistent spinal and complex regional pain syndromes 6. Their work highlights the critical importance of appropriately selecting patients for optimizing outcomes.…”